Home > Insider Trading > Filing (0001437749-16-034195)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879682	Viveve Medical Inc.	VIVE	Electromedical & Electrotherapeutic Apparatus (3845)	043153858

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1270925	P Timothy Lynch	P.o. Box 250 Bend OR 97709	No	No	Yes	No
1370042	Stonepine Capital, L.p.	P.o. Box 250 Bend OR 97709	No	No	Yes	No
1440771	Stonepine Capital Management, Llc	P.o. Box 250 Bend OR 97709	No	No	Yes	No
1462580	M Jon Plexico	P.o. Box 250 Bend OR 97709	Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-17	300,000	$5.00	2,599,711	No	4	P	Indirect	See

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See

Footnotes

Stonepine Capital, L.P. (the "Fund") purchased these shares in connection with the closing of a public offering of the Issuer's common stock (the "Offering") at the Offering price of $5.00 per share. The shares are subject to a lock-up provision for a period of 90 days following June 14, 2016, as required under a lock-up agreement with the underwriters of the Offering.
On April 15, 2016, the Issuer effected a 1-for-8 reverse stock split of its common stock (the "Split"), which began trading on a post-Split basis on April 18, 2016. The amount reported in Column 5 represents securities beneficially owned on a post-Split basis.
The filers (the "Filers") are Stonepine Capital Management, LLC (the "General Partner"), the Fund, Jon M. Plexico and Timothy P. Lynch. The General Partner is the general partner and investment adviser of the Fund. Mr. Plexico and Mr. Lynch are the General Partner's managers and control persons. These securities are held directly by the Fund for the benefit of its investors and are indirectly beneficially owned by the General Partner and Mr. Plexico and Mr. Lynch as the General Partner's control persons. Each Filer disclaims beneficial ownership of these securities except to the extent of that Filer's pecuniary interest therein.